Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Items 101–200 of 1,000
Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
Arvanitakis, K., Κoletsa, T., Mitroulis, I., & Germanidis, G. S. (2022) · Cancers · doi:10.3390/cancers14010226 · Cited by 144
“M2 macrophages initiate the Th2 immune response, promoting angiogenesis, tissue remodeling and repair [53,54].”
BackgroundRegulation of inflammation by members of the formyl-peptide receptor family
Chen, K., Bao, Z., Gong, W., Tang, P., Yoshimura, T., & Wang, J. M. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.012 · Cited by 135
A role for CCL2 in both tumor progression and immunosurveillance
Li, M., Knight, D. A., Snyder, L. A., Smyth, M. J., & Stewart, T. J. (2013) · OncoImmunology · doi:10.4161/onci.25474 · Cited by 125
Liou, G.-Y., Bastea, L., Fleming, A., Döppler, H., Edenfield, B. H., Dawson, D. W., Zhang, L., Bardeesy, N., & Storz, P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.052 · Cited by 127
Nanoparticles for tumor immunotherapy
Zang, X., Zhao, X., Hu, H., Qiao, M., Deng, Y., & Chen, D. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.03.013 · Cited by 136
The Role of Selected Chemokines and Their Receptors in the Development of Gliomas
Groblewska, M., Litman‐Zawadzka, A., & Mroczko, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103704 · Cited by 131
Combinatorial therapy in tumor microenvironment: Where do we stand?
Kumari, S., Advani, D., Sharma, S., Ambasta, R. K., & Kumar, P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188585 · Cited by 128
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
Marques, P., Barry, S., Carlsen, E., Collier, D., Ronaldson, A., Awad, S., Dorward, N., Grieve, J., Mendoza, N., Muquit, S., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0830-3 · Cited by 131
Compensatory angiogenesis and tumor refractoriness
Gacche, R. N. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.14 · Cited by 111
Liao, Q., Zeng, Z., Guo, X., Li, X., Wei, F., Zhang, W., Li, X., Chen, P., Liang, F., Xiang, B., et al. (2013) · Oncogene · doi:10.1038/onc.2013.161 · Cited by 121
Patwardhan, P. P., Surriga, O., Beckman, M. J., de Stanchina, E., Dematteo, R. P., Tap, W. D., & Schwartz, G. K. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2576 · Cited by 118
“Macrophages are typically divided into two types: classically activated or M1 and alternatively activated or M2 (44).”
Annexin A1 as a Regulator of Immune Response in Cancer
Araújo, T. G., Mota, S. T. S., Ferreira, H. S. V., Ribeiro, M. A., Goulart, L. R., & Vecchi, L. (2021) · Cells · doi:10.3390/cells10092245 · Cited by 121
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications
Huang, Q., Liang, X., Ren, T., Huang, Y., Zhang, H., Yu, Y., Chen, C., Wang, W., Niu, J., Lou, J., et al. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00598-w · Cited by 118
“receptor antagonists (IL-1ra), and M2c macrophages by IL10, TGF-β or glucocorticoids (GCs) [43].”
BackgroundChang, N., Ahn, S. H., Kong, D., Lee, H. W., & Nam, D. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.004 · Cited by 121
“…microglia and in M2 tumor-associated macrophages (TAMs); this results in suppression of antitumor mechanisms, or even tolerance to tumor antigens (Hao et al., 2012; Hussain et al., 2006; Joshi et al., 2007; Kostianovsky et al., 2008; Lo et al., 2007; Martinez and Gordon, 2014; Payasi et al.,…”
BackgroundMirzadeh, M., Lelekami, A. K., & Khedmat, L. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118134 · Cited by 123
Rojas, J. M., Sanz-Ortega, L., Mulens‐Arias, V., Gutiérrez, L., Pérez-Yagüe, S., & Barber, D. F. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.11.020 · Cited by 122
“M2 macrophages can be polarised by distinct stimuli such as Th2 cytokines (IL-4 or IL-13), immune complexes, lipopolysaccharides (LPS), Toll-like receptor (TLR) ligation, IL-1 receptor agonist, IL-10, TGF-, glucocorticoid [7], or the adenosine A2A receptor [8], resulting in a wide spectrum of M2 polarised phenotypes…”
BackgroundInfluentialThe impact of surface chemistry modification on macrophage polarisation
Rostam, H. M., Singh, S., Salazar, F., Magennis, P., Hook, A., Singh, T., Vrana, N. E., Alexander, M. R., & Ghaemmaghami, A. M. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.06.010 · Cited by 114
Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine
Aleskandarany, M. A., Vandenberghe, M. E., Marchiò, C., Ellis, I. O., Sapino, A., & Rakha, E. A. (2018) · Pathobiology · doi:10.1159/000477851 · Cited by 122
Nanomedicine Strategies to Target Tumor-Associated Macrophages
Binnemars-Postma, K., Storm, G., & Prakash, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050979 · Cited by 108
“Also, because of the presence of arginase in these cells, arginine is not metabolized towards NO but to ornithine and polyamines, which are necessary for collagen synthesis and cellular proliferation [27].”
BackgroundTGFΒ-induced transcription in cancer
Cantelli, G., Crosas-Molist, E., Georgouli, M., & Sanz-Moreno, V. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.08.009 · Cited by 111
“Morever, TGF secreted by lung cancer cells induces Treg cells in he lung tumour microenvironment [66].”
BackgroundDeng, F., He, S., Cui, S., Shi, Y., Tan, Y., Li, Z., Huang, C., Liu, D., Zhi, F., & Peng, L. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy181 · Cited by 112
Galletti, G., Scielzo, C., Barbaglio, F., Rodríguez, T. V., Riba, M., Lazarević, D., Cittaro, D., Simonetti, G., Ranghetti, P., Scarfò, L., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.042 · Cited by 117
García-Culebras, A., Durán-Laforet, V., Peña-Martínez, C., Ballesteros, I., Pradillo, J. M., Díaz-Guzmán, J., Lizasoain, I., & Moro, M. A. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18795789 · Cited by 111
Weiss, S. A., Djureinovic, D., Jessel, S., Krykbaeva, I., Zhang, L., Jilaveanu, L., Ralabate, A., Johnson, B., Levit, N. S., Anderson, G., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0903 · Cited by 102
Bai, J., Adriani, G., Dang, T.-M., Tu, T.-Y., Leong Penny, H.-X., Wong, S.-C., Kamm, R. D., & Thiery, J.-P. (2015) · Oncotarget · doi:10.18632/oncotarget.4716 · Cited by 110
Song, W., Mazzieri, R., Yang, T., & Gobe, G. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01106 · Cited by 112
“Changes in the relative ratios between pro-inflammatory and immunosuppressive/ remodeling factors characterize a more M1-like or M2-like polarization state (55).”
BackgroundObesity, metabolism and the microenvironment: Links to cancer
Makowski, L., Sundaram, S., & Johnson, A. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.119606 · Cited by 115
“[108] B cells in the microenvironment can also skew macrophage function and promote tumor progression via IL‐10 induction.[108,109] Animal models of BC have demonstrated that inflammatory processes contribute to tumor proliferation and metastasis while anti‐inflammatory drugs are chemopreventive.”
BackgroundAkimoto, M., Maruyama, R., Takamaru, H., Ochiya, T., & Takenaga, K. (2016) · Nature Communications · doi:10.1038/ncomms13589 · Cited by 110
Azhdari, S., Moghaddam, A. S., Abdollahi, E., Johnston, T. P., Ghaneifar, Z., Vahedi, P., & Goleij, P. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220324114624 · Cited by 110
Li, M., Luo, H., Wu, X. Y., Liu, Y., Gan, Y., Xu, N., Zhang, Y.-M., Zhang, S., Zhou, C., Su, Z., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01552 · Cited by 110
Deng, Y., Li, M., Chen, L.-X., Chen, X., Lu, J., Zhao, J., & Li, S. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.10.026 · Cited by 104
Immunosuppressive Mechanisms of Regulatory Dendritic Cells in Cancer
Shurin, G. V., Ma, Y., & Shurin, M. R. (2013) · Cancer Microenvironment · doi:10.1007/s12307-013-0133-3 · Cited by 114
“For instance, TGF-β promotes tumor-associated macrophage polarization to an M2-versus-M1 phenotype, which further promotes TGF-β production and deepens immunosuppression [38].”
BackgroundTargeting tumor-associated macrophages to combat pancreatic cancer
Cui, R., Yue, W., Lattime, E. C., Stein, M. N., Xu, Q., & Tan, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9383 · Cited by 110
“The role of TAM-derived cytokines, chemokines, and proteases in immunosuppression has been reviewed previously [98].”
BackgroundLoss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis
Ortiz, B., Fabius, A. W. M., Wu, W., Pedraza, A. M., Brennan, C., Schultz, N. D., Pitter, K. L., Bromberg, J., Huse, J. T., Holland, E. C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401952111 · Cited by 106
Ambade, A., Satishchandran, A., Saha, B., Gyongyosi, B., Lowe, P., Kodys, K., Catalano, D., & Szabo, G. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1221557 · Cited by 96
“Interestingly, M2c macrophages play a prominent role in suppressing immune responses and promoting tissue remodeling.(32) Recently these M2c macrophages were shown to promote tumor invasion and growth in a lung carcinoma model.”
BackgroundMohamed, M. M., Elghonaimy, E. A., Nouh, M. A., Schneider, R. J., Sloane, B. F., & El‐Shinawi, M. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.11.015 · Cited by 104
“Classical activation induces the secretion of pro-inflammatory mediators by the macrophages and recruitment of T-cells as in an early inflammatory response (Ojalvo et al., 2009).”
BackgroundLiu, H., Zhao, H., & Sun, Y. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.004 · Cited by 108
Induction of Murine Macrophage M2 Polarization by Cigarette Smoke Extract via the JAK2/STAT3 Pathway
Yuan, F., Fu, X., Shi, H., Chen, G., Dong, P., & Zhang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107063 · Cited by 96
“Furthermore, M1 macrophages express high levels of MHC II and secrete complement factors that facilitate complement-mediated phagocytosis [9].”
BackgroundTafani, M., Pucci, B., Russo, A., Schito, L., Pellegrini, L., Perrone, G. A., Villanova, L., Salvatori, L., Ravenna, L., Petrangeli, E., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00013 · Cited by 99
“…the presence of an active local immuneinflammatory response with activated leukocytes and on many other factors (Zigler et al., 2010; Noman et al., 2011; Coleman et al., 2012; Hanahan and Coussens, 2012; Hao et al., 2012; Mucaj et al., 2012; Muratori and Tamagnone, 2012; Nasr and Pelletier, 2012).”
BackgroundYang, Y., Wang, X., Huycke, T., Moore, D. R., Lightfoot, S. A., & Huycke, M. M. (2013) · Translational Oncology · doi:10.1593/tlo.13412 · Cited by 94
“In contrast to the role of M2-polarized (or tumor-associated) macrophages in promoting tumor progression [13], our findings suggest that M1-polarized macrophages— phagocytes that ordinarily help resolve acute infections—can initiate cellular transformation through BSE when chronically activated.”
BackgroundResultInfluentialDamanik, F. F. R., Rothuizen, T. C., van Blitterswijk, C., Rotmans, J. I., & Moroni, L. (2014) · Scientific Reports · doi:10.1038/srep06325 · Cited by 97
Small cell lung cancer: Recruitment of macrophages by circulating tumor cells
Hamilton, G., Rath, B., Klameth, L., & Hochmair, M. J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1093277 · Cited by 98
“Specifically, M2b macrophages are activated by immune complexes, toll-like receptor-positive lymphocytes, or IL-1ra.(33) Pf4/CXCL4 has been demonstrated to prevent monocyte apoptosis and to promote macrophage differentiation from peripheral blood monocytes.”
BackgroundE‐cigarettes, nicotine, the lung and the brain: multi‐level cascading pathophysiology
Herman, M. A., & Tarran, R. (2020) · The Journal of Physiology · doi:10.1113/jp278388 · Cited by 106
“Alveolar macrophages exhibit functional heterogeneity/plasticity (Gordon & Taylor, 2005; Hao et al. 2012).”
BackgroundSenescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer
Choi, Y. W., Kim, Y. H., Oh, S. Y., Suh, K. W., Kim, Y., Lee, G., Yoon, J. E., Park, S. S., Lee, Y., Park, Y. J., et al. (2021) · Advanced Science · doi:10.1002/advs.202002497 · Cited by 102
Shiri, S., Alizadeh, A. M., Baradaran, B., Farhanghi, B., Shanehbandi, D., Khodayari, S., Khodayari, H., & Tavasoli, A. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.3917 · Cited by 101
Jafarzadeh, N., Safari, Z., Pornour, M., Amirizadeh, N., Moghadam, M. F., & Sadeghizadeh, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27142 · Cited by 97
“It has been widely accepted that in the majority of malignancies, the infiltrated macrophages are reprogrammed to gain M2 phenotype, which contributes to tumor‐ associated immunosuppression, angiogenesis, and tumor growth (Hao et al., 2012).”
BackgroundResolvin D1 and D2 inhibit tumour growth and inflammation via modulating macrophage polarization
Shan, K., Feng, N., Cui, J., Wang, S., Qu, H., Fu, G., Li, J., Chen, H., Wang, X., Wang, R., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15436 · Cited by 99
Wang, H., Chen, C.-W., Yang, C.-L., Tsai, I.-M., Hou, Y., Chen, C.-J., & Shan, Y. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0295 · Cited by 93
Vila-Caballer, M., Codolo, G., Munari, F., Malfanti, A., Fassan, M., Rugge, M., Balasso, A., de Bernard, M., & Salmaso, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.024 · Cited by 93
“Studies performed to yield macrophage targeting have shown that the liposome uptake by macrophages depends on a variety of features, including size, charge and composition [65], although the macrophage heterogeneity has not allowed to extensively elucidate the impact of liposome features on the immune response [64,66].”
BackgroundThe Role of Inflammation in Prostate Cancer
Sfanos, K. S., Hempel, H., & Marzo, A. M. D. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_7 · Cited by 104
Zhao, S.-J., Jiang, Y.-Q., Xu, N.-W., Li, Q., Zhang, Q., Wang, S.-Y., Li, J., Wang, Y.-H., Zhang, Y.-L., Jiang, S.-H., et al. (2018) · Oncogene · doi:10.1038/onc.2017.403 · Cited by 89
Self-citationDuan, M., Xu, Y., Li, Y., Feng, H., & Chen, Y. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03101-y · Cited by 93
“…the areas of activated macrophage aggregation, which suggests that there may be interactions between T cells and macrophages [253]; however, there is also evidence that T-cell-produced IL-4 can promote the conversion of macrophages to the M2 phenotype, thereby suppressing inflammation [254, 255].”
BackgroundMeng, F., Li, W., Li, C., GAO, Z., Guo, K., & Song, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2794 · Cited by 97
Malignant transformation of oral leukoplakia is associated with macrophage polarization
Weber, M., Wehrhan, F., Baran, C., Agaimy, A., Büttner-Herold, M. J., Öztürk, H., Neubauer, K., Wickenhauser, C., Kesting, M. R., & Ries, J. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-019-02191-0 · Cited by 89
Kaushik, N. K., Kaushik, N., Min, B., Choi, K. H., Hong, Y. J., Miller, V., Fridman, A., & Choi, E. H. (2016) · Journal of Physics D Applied Physics · doi:10.1088/0022-3727/49/8/084001 · Cited by 96
Gabrusiewicz, K., Liu, D., Cortes-Santiago, N., Hossain, M. B., Conrad, C. A., Aldape, K. D., Fuller, G. N., Marini, F. C., Alonso, M. M., Idoate, M. A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1893 · Cited by 84
“To understand the role of stroma on invasive glioma growth, we analyzed first for the presence of microglia/macrophages, which have been reported to be associated with adaptive resistance to anti-angiogenic therapy [27, 28].”
BackgroundLechien, J. R., Descamps, G., Seminerio, I., Furgiuele, S., Dequanter, D., Mouawad, F., Badoual, C., Journé, F., & Saussez, S. (2020) · Cancers · doi:10.3390/cancers12051060 · Cited by 91
Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome
Pimenta, M. G., Otero, Á., Guzmán, D. Á. A., Argente, D. P., Martín, L. R., Sousa-Casasnovas, P., García-Martín, A., de Oca, J. C. R. M., Ledezma, J. J. V., Carretero, L. T., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12927 · Cited by 89
“Here, we investigated the pattern of expression of three (CD192, CD206, and CD163) markers that have been related to these two different polarization states of TAM (52,53).”
BackgroundLiving Leukocyte‐Based Drug Delivery Systems
Chen, Y., Qin, D., Zou, J., Li, X., Guo, X. D., Tang, Y., Chuang, L. I. U., Chen, W., Kong, N., Zhang, C. Y., et al. (2022) · Advanced Materials · doi:10.1002/adma.202207787 · Cited by 97
Lee, J.-H., Lee, G. T., Woo, S. H., Ha, Y.-S., Kwon, S. J., Kim, W.-J., & Kim, I. Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4563 · Cited by 87
Ishimoto, T., Sugihara, H., Watanabe, M., Sawayama, H., Iwatsuki, M., Baba, Y., Okabe, H., Hidaka, K., Yokoyama, N., Miyake, K., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt402 · Cited by 86
“Recent studies determined that M1- and M2-polarized macrophages play different functional roles in the tumor microenvironment (12,13).”
BackgroundMaimon, A., Levi-Yahid, V., Ben‐Meir, K., Halpern, A., Talmi, Z., Priya, S., Mizraji, G., Mistriel-Zerbib, S., Berger, M., Baniyash, M., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci126089 · Cited by 89
“We hypothesized that the elevated frequencies of Pros1-deficient myeloid cells provoking a protumor effect originate from the circulation, as seen in a variety of cancer models (1, 3, 11, 30).”
Xue, Z., Liu, J., Xing, W., Mu, F., Wu, Y., Zhao, J., Liu, X., Wang, D., Wang, J., Li, X., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02888-5 · Cited by 87
“Specifically, infiltrating macrophages are instrumental in fostering tumor angiogenesis, expansion, and resistance to therapeutic agents through the secretion of an array of cytokines and chemokines [6, 7].”
BackgroundSun, P., Wang, H., He, Z., Chen, X., Wu, Q., Chen, W., Sun, Z., Weng, M., Zhu, M., Ma, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20301 · Cited by 81
“It is generally accepted that TAMs can shield tumor immune surveillance and stimulate new blood vessel formation, induce proliferation of cancer cells, facilitate local invasion and distant metastasis of tumor cells [7, 8].”
BackgroundYamamoto, K., Makino, T., Sato, E., Noma, T., Urakawa, S., Takeoka, T., Yamashita, K., Saito, T., Tanaka, K., Takahashi, T., et al. (2020) · Cancer Science · doi:10.1111/cas.14328 · Cited by 85
Tan, M., Zhao, Q., & Zhao, B. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.226 · Cited by 85
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma
Wang, Q., Lu, Y., Li, R., Jiang, Y., Zheng, Y., Qian, J., Bi, E., Zheng, C., Hou, J., Wang, S., et al. (2017) · Leukemia · doi:10.1038/leu.2017.193 · Cited by 89
Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications
Zhu, S., Luo, Z., Li, X., Han, X., Shi, S., & Zhang, T. (2020) · Journal of Cancer · doi:10.7150/jca.49692 · Cited by 86
HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism
Armando Rojas, R., Delgado‐López, F., Pérez-Castro, R., González, I., Romero, J. A., Rojas, I., Araya, P., Añazco, C. C., Morales, E., & Jorge Llanos, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-3940-y · Cited by 84
Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas
Weber, M., Iliopoulos, C., Möbius, P., Büttner-Herold, M. J., Amann, K., Ries, J., Preidl, R. H. M., Neukam, F. W., & Wehrhan, F. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.11.001 · Cited by 84
In Vivo Visualization of Stromal Macrophages via label-free FLIM-based metabolite imaging
Szulczewski, J. M., Inman, D. R., Entenberg, D. R., Ponik, S. M., Aguirre‐Ghiso, J. A., Castracane, J., Condeelis, J. S., Eliceiri, K. W., & Keely, P. J. (2016) · Scientific Reports · doi:10.1038/srep25086 · Cited by 91
Trivedi, M., Talekar, M., Shah, P., Ouyang, Q., & Amiji, M. M. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.52 · Cited by 84
Kim, M., Min, Y. K., Jang, J., Park, H., Lee, S., & Lee, C. H. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002503 · Cited by 89
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Chen, C., Hutzen, B. J., Wedekind, M. F., & Cripe, T. P. (2018) · Oncolytic Virotherapy · doi:10.2147/ov.s145532 · Cited by 88
“109,110 Targeting these immunosuppressive factors together with oncolytic virotherapy and checkpoint blockade may broaden the application of immunotherapy and improve antitumor efficacy.”
Evidence linking exposure of fish primary macrophages to antibiotics activates the NF-kB pathway
Qiu, W., Hu, J., Magnuson, J. T., Greer, J. B., Yang, M., Chen, Q., Fang, M., Zheng, C., & Schlenk, D. (2020) · Environment International · doi:10.1016/j.envint.2020.105624 · Cited by 89
Furudate, S., Fujimura, T., Kakizaki, A., Kambayashi, Y., Asano, M., Watabe, A., & Aiba, S. (2015) · Experimental Dermatology · doi:10.1111/exd.12873 · Cited by 82
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
Fujii, K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00198 · Cited by 84
“TAMs usually comprise polarized M2 macrophages that contribute to an immune-suppressive environment and promote tumor cell growth (79).”
BackgroundlncRNA GAS5 promotes M1 macrophage polarization via miR‐455‐5p/SOCS3 pathway in childhood pneumonia
Chi, X., Ding, B., Zhang, L., Zhang, J., Wang, J., & Zhang, W. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27996 · Cited by 82
“In contrast, M2 macrophages express anti‐inflammatory cytokines, such as IL‐10 and transforming growth factor β (TGF‐β; Hao et al., 2012; Sindrilaru et al., J Cell Physiol.”
BackgroundChimal-Ramírez, G. K., Espinoza‐Sánchez, N. A., & Fuentes‐Pananá, E. M. (2013) · Journal of Oncology · doi:10.1155/2013/835956 · Cited by 88
The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma
You, J., Chen, W., Chen, J., Zheng, Q., Dong, J., & Zhu, Y. (2018) · BioMed Research International · doi:10.1155/2018/2109865 · Cited by 80
“ARG1 encodes the arginase I isoform, which is confirmed to be located in the cytoplasm and highly expressed in liver andM2macrophages [9].”
BackgroundMoradi‐Chaleshtori, M., Bandehpour, M., Heidari, N., Mohammadi‐Yeganeh, S., & Hashemi, S. M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107198 · Cited by 83
The importance of the tumor microenvironment in the therapeutic management of cancer
Pottier, C., Wheatherspoon, A., Roncarati, P., Longuespée, R., Herfs, M. F., Duray, A., Delvenne, P., & Quatresooz, P. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1059279 · Cited by 89
“) and cytokines (IL-1, IL-6, IL-12, IL-23, TNF-a, iNOS), whereas type 2 macrophages produce anti-inflammatory molecules (IL-10, TGF-b, arginase1, proteolytic enzymes and angiogenic factors) and are mainly involved in tissue remodeling, immunosuppression and tumor promotion [7].”
BackgroundNing, C., Xie, B., Zhang, L., Li, C., Shan, W., Yang, B., Luo, X., Gu, C., He, Q., Jin, H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1260 · Cited by 82
Self-citationGray, M. J., Gong, J., Hatch, M. M. S., Nguyen, V., Hughes, C. C. W., Hutchins, J. T., & Freimark, B. D. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0708-2 · Cited by 83
“A shift to a M1 phenotype using a PS blocking antibody has been reported previously [22], but the prognostic value of the increase in the overall percentage of macrophages remains unknown [61–63].”
Gu, S., & Feng, X. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy092 · Cited by 84
“In lung tumor, TGF-β secreted by lung cancer cells induces Treg cells in tumor microenvironment [92].”
BackgroundResearch Progress on Tumor‐Associated Macrophages and Inflammation in Cervical Cancer
Liu, Y., Li, L., Li, Y., & Zhao, X. (2020) · BioMed Research International · doi:10.1155/2020/6842963 · Cited by 83
“0e bidirectional effect of lymphocytes and other inherent lymphoid cell subsets occurred during the resolution of inflammation and wound healing of macrophages after infection or injury [20, 21].”
BackgroundHao, W., Wang, S., Zhao, J., & Li, S. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113219 · Cited by 79
Lin, Z., Liao, W., & Ren, J. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b01387 · Cited by 82
Boddupalli, A., Zhu, L., & Bratlie, K. M. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600532 · Cited by 76
Silva, V. L., & Al-Jamal, W. T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.013 · Cited by 78
“They over-express scavenger receptors, mannose receptors and exhibit anti-inflammatory activity [94,95].”
BackgroundThe role of immune-related myeloid cells in angiogenesis
Chambers, S. E. J., O’Neill, C. L., O’Doherty, T. M., Medina, R. J., & Stitt, A. W. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.010 · Cited by 87
Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages
Kwon, Y., Kim, M.-S., Kim, Y., Jung, H. S., & Jeoung, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01167 · Cited by 81
“TAMs induce immunosuppressive and tumorigenic functions, and express the enzyme Arg1.”
BackgroundInfluentialZheng, L., Wang, B., Sun, Y., Dai, B., Fu, Y., Zhang, Y., Wang, Y., Yang, Z., Sun, Z., Zhuang, S., et al. (2021) · ACS Sensors · doi:10.1021/acssensors.0c01846 · Cited by 78
Zhou, L., Li, J., Liao, M., Zhang, Q., & Yang, M. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03055-7 · Cited by 79
Mazur, A., Holthoff, E. R., Vadali, S., Kelly, T. J., & Post, S. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150287 · Cited by 85
“Tumor associated macrophages (TAMs) typically exhibit an M2 phenotype and are associated with secretion of a wide variety of growth factors, cytokines, and chemokines that suppress an anti-tumor immune response and promote tumor growth [16, 17].”
BackgroundTakeuchi, H., Tanaka, M., TANAKA, A., Tsunemi, A., & Yamamoto, H. (2016) · Oncology Letters · doi:10.3892/ol.2016.4392 · Cited by 78
“In the tumor microenvironment, the majority of TAMs exhibit an M2-like phenotype (6), exert anti‑inflammatory and protumor effects, and facilitate tumor growth, angiogenesis, immunosuppression and matrix remodeling (14).”
Bailey‐Downs, L. C., Thorpe, J. E., Disch, B. C., Bastian, A., Hauser, P. J., Farasyn, T., Berry, W. L., Hurst, R. E., & Ihnat, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098624 · Cited by 81
Kakizaki, A., Fujimura, T., Furudate, S., Kambayashi, Y., Yamauchi, T., Yagita∥, H., & Aiba, S. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1047584 · Cited by 76
Evolutionary Aspects of Macrophages Polarization
Edholm, E., Rhoo, K. H., & Robert, J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-54090-0_1 · Cited by 82
“…were expressed in the tnfa+ macrophages, whereas tnfa− macrophages expressed TGF-β, C-C chemokine receptor type 2 (CCR2), and C-X-C chemokine receptor type 4 (CXCR4), which are markers of M2 activation in mammals (Beider et al. 2014; Hao et al. 2012; Mantovani et al. 2002; Martinez et al. 2006).”
BackgroundCui, L., Yang, G., Ye, J., Yao, Y., Lu, G., Chen, J., Fang, L., Lu, S., & Zhou, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15563 · Cited by 75
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.